| Simra Javaid, DO | |
|
1333 Moursund St Ste 129, Houston, TX 77030-3405 | |
| (713) 797-5929 | |
| (713) 797-5988 |
| Full Name | Simra Javaid |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation - Pediatric Rehabilitation Medicine |
| Location | 1333 Moursund St Ste 129, Houston, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073923181 | NPI | - | NPPES |
| Entity Name | Ut Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033157821 PECOS PAC ID: 8426960360 Enrollment ID: O20031107000268 |
News Archive
Finding an immune system in the social amoeba (Dictyostelium discoideum) is not only surprising but it also may prove a clue as to what is necessary for an organism to become multicellular, said the Baylor College of Medicine researcher who led the research that appears in the journal Science.
Boston Scientific Corporation today announced the signing of a definitive merger agreement, under which the Company will acquire Atritech, a privately held company based in Plymouth, Minnesota.
ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the fourth quarter and year ended December 31, 2010.
Idera Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune diseases and genetically defined forms of B-cell lymphoma, today announced that enrollment is open for a Phase 1/2 clinical trial of IMO-8400 in patients with Waldenström's macroglobulinemia, following acceptance of its Investigational New Drug application by the U.S. Food and Drug Administration.
› Verified 5 days ago
| Entity Name | Physicians Referral Service |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073574810 PECOS PAC ID: 7911801410 Enrollment ID: O20031125000953 |
News Archive
Finding an immune system in the social amoeba (Dictyostelium discoideum) is not only surprising but it also may prove a clue as to what is necessary for an organism to become multicellular, said the Baylor College of Medicine researcher who led the research that appears in the journal Science.
Boston Scientific Corporation today announced the signing of a definitive merger agreement, under which the Company will acquire Atritech, a privately held company based in Plymouth, Minnesota.
ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the fourth quarter and year ended December 31, 2010.
Idera Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune diseases and genetically defined forms of B-cell lymphoma, today announced that enrollment is open for a Phase 1/2 clinical trial of IMO-8400 in patients with Waldenström's macroglobulinemia, following acceptance of its Investigational New Drug application by the U.S. Food and Drug Administration.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Simra Javaid, DO 1333 Moursund St Ste 129, Houston, TX 77030-3405 Ph: (713) 797-5929 | Simra Javaid, DO 1333 Moursund St Ste 129, Houston, TX 77030-3405 Ph: (713) 797-5929 |
News Archive
Finding an immune system in the social amoeba (Dictyostelium discoideum) is not only surprising but it also may prove a clue as to what is necessary for an organism to become multicellular, said the Baylor College of Medicine researcher who led the research that appears in the journal Science.
Boston Scientific Corporation today announced the signing of a definitive merger agreement, under which the Company will acquire Atritech, a privately held company based in Plymouth, Minnesota.
ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the fourth quarter and year ended December 31, 2010.
Idera Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune diseases and genetically defined forms of B-cell lymphoma, today announced that enrollment is open for a Phase 1/2 clinical trial of IMO-8400 in patients with Waldenström's macroglobulinemia, following acceptance of its Investigational New Drug application by the U.S. Food and Drug Administration.
› Verified 5 days ago
Dr. Suzanne Marie Manzi, M.D., FAAPMR Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4126 Southwest Fwy Ste 1700, Houston, TX 77027 Phone: 346-217-1111 Fax: 346-571-2189 | |
Miguel Ernesto Velez, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2727 W Holcombe Blvd, Houston, TX 77025 Phone: 713-442-0000 | |
Sara Goel, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 7700 Main St Ste 400, Houston, TX 77030 Phone: 346-230-4070 Fax: 281-605-6804 | |
Dr. Michael Krebs, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 5202 Redstart St, Houston, TX 77035 Phone: 281-531-5200 Fax: 281-531-5430 | |
Dr. Tova Liana Alladice, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 8200 Wednesbury Ln, Suite 360, Houston, TX 77074 Phone: 713-484-6200 Fax: 713-773-0905 | |
Susan Victoria Kattula Gammon, OTR/L Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 6621 Fannin St., Houston, TX 77030 Phone: 832-826-6121 Fax: 630-792-1801 | |
Savitha Bonthala, D.O., M.P.H. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1300 Binz St Fl 3, Houston, TX 77004 Phone: 713-285-1000 |